Literature DB >> 16772368

T cell receptor cross-recognition of an HIV-1 CD8+ T cell epitope presented by closely related alleles from the HLA-A3 superfamily.

Mathias Lichterfeld1, Katie L Williams, Stanley K Mui, Shivani S Shah, Bianca R Mothe, Alessandro Sette, Arthur Kim, Mary N Johnston, Nicole Burgett, Nicole Frahm, Daniel Cohen, Christian Brander, Eric S Rosenberg, Bruce D Walker, Marcus Altfeld, Xu G Yu.   

Abstract

HLA-A3 and -A11 share similar peptide-binding motifs, however, it is unclear if promiscuous epitope presentation by HLA-A3 or HLA-A11 is associated with promiscuous TCR recognition. Here, we show that despite widespread cross-presentation of identical HIV-1 peptides in HIV-1-infected individuals expressing HLA-A3 or HLA-A11, peptides presented by HLA-A3 or HLA-A11 commonly exhibited clear immune distinctiveness with exclusive TCR recognition. Yet, using HLA-A3 and HLA-A11 tetramers for testing T cell cross-recognition of the HIV-1 Nef QK10 epitope, we observed in two study persons that specific CD8+ T cell populations were able to cross-recognize this peptide in the context of both HLA-A3 and HLA-A11. This cross-recognition was mediated by single cross-reactive TCRs, as shown by TCR sequencing in conjunction with TCR Vbeta chain immunostaining. In each cross-reactive cell population, multiple TCR beta chain variants were detected in the presence of only one TCR alpha chain variant. Thus, despite distinct TCR recognition of HLA-A3 or HLA-A11 presented HIV-1 peptides in the vast majority of cases, specific TCRs can cross-recognize their antigen in the context of both HLA-A3 and HLA-A11.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16772368     DOI: 10.1093/intimm/dxl052

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  8 in total

1.  High-functional-avidity cytotoxic T lymphocyte responses to HLA-B-restricted Gag-derived epitopes associated with relative HIV control.

Authors:  Christoph T Berger; Nicole Frahm; David A Price; Beatriz Mothe; Musie Ghebremichael; Kari L Hartman; Leah M Henry; Jason M Brenchley; Laura E Ruff; Vanessa Venturi; Florencia Pereyra; John Sidney; Alessandro Sette; Daniel C Douek; Bruce D Walker; Daniel E Kaufmann; Christian Brander
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

2.  Cross-allele cytotoxic T lymphocyte responses against 2009 pandemic H1N1 influenza A virus among HLA-A24 and HLA-A3 supertype-positive individuals.

Authors:  Jun Liu; Shihong Zhang; Shuguang Tan; Yong Yi; Bin Wu; Bin Cao; Fengcai Zhu; Chen Wang; Hua Wang; Jianxun Qi; George F Gao
Journal:  J Virol       Date:  2012-09-26       Impact factor: 5.103

3.  Human leukocyte antigens A*3001 and A*3002 show distinct peptide-binding patterns of the Mycobacterium tuberculosis protein TB10.4: consequences for immune recognition.

Authors:  Rebecca Axelsson-Robertson; Raija K Ahmed; Frank F Weichold; Marthie M Ehlers; Marleen M Kock; Donata Sizemore; Jerry Sadoff; Markus Maeurer
Journal:  Clin Vaccine Immunol       Date:  2010-11-17

4.  Altered decamer and nonamer from an HLA-A0201-restricted epitope of Survivin differentially stimulate T-cell responses in different individuals.

Authors:  Chantale Bernatchez; Kuichin Zhu; Yufeng Li; Helen Andersson; Constantin Ionnides; Marcelo Fernandez-Vina; Pedro Cano; Laurence Cooper; James Abbruzzese; Patrick Hwu; David Z Chang; Laszlo G Radvanyi
Journal:  Vaccine       Date:  2011-02-12       Impact factor: 3.641

Review 5.  Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine development.

Authors:  Zuzana Staneková; Eva Varečková
Journal:  Virol J       Date:  2010-11-30       Impact factor: 4.099

6.  HLA class I supertypes: a revised and updated classification.

Authors:  John Sidney; Bjoern Peters; Nicole Frahm; Christian Brander; Alessandro Sette
Journal:  BMC Immunol       Date:  2008-01-22       Impact factor: 3.615

7.  Dynamic Perturbations of the T-Cell Receptor Repertoire in Chronic HIV Infection and following Antiretroviral Therapy.

Authors:  James M Heather; Katharine Best; Theres Oakes; Eleanor R Gray; Jennifer K Roe; Niclas Thomas; Nir Friedman; Mahdad Noursadeghi; Benjamin Chain
Journal:  Front Immunol       Date:  2016-01-11       Impact factor: 7.561

8.  Structural basis for the differential classification of HLA-A*6802 and HLA-A*6801 into the A2 and A3 supertypes.

Authors:  Ling Niu; Hao Cheng; Shihong Zhang; Shuguang Tan; Yudan Zhang; Jianxun Qi; Jun Liu; George F Gao
Journal:  Mol Immunol       Date:  2013-04-06       Impact factor: 4.407

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.